Search For "pharma major"
Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG
Updated : 1 week, 3 days ago IST
Mumbai (Maharashtra) [India], March 6: Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its recognition among the top 1% of companies worldwide in the S&P Global Corporate Sustainability Assessment (CSA). Lupin attain
Read More
Morepen Bags Rs. 825 Crore Global Deal
Updated : 1 week, 3 days ago IST
Gurugram (Haryana) [India], February 23: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major.
Read More
Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Se
Updated : 1 week, 3 days ago IST
Mumbai (Maharashtra) [India], February 4: Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received the highest 'A' leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishmen
Read More
STL reports Q3 FY'26 results; strengthens technology leadership
Updated : 2 months ago IST
Mumbai (Maharashtra) [India], January 23: STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure, today announced its financial results for the quarter ended 31st December 2025. For Q3 FY'26, the Company reported revenues of INR 1,257 Cr and EBITDA
Read More
Lupin's R&D Facility in Pune Awarded LEED Platinum Certification
Updated : 1 year, 3 months ago IST
Mumbai (Maharashtra) [India], December 6: Global pharma major Lupin Limited (Lupin) today announced that its R&D facility at Lupin Research Park, Pune has been awarded the LEED Platinum Certification for Operations and Maintenance by the U.S. Green Building Council (USGBC), the global le
Read More
US FDA inspection closed at its Injectable Facility with Zero 483 observat
Updated : 1 year, 9 months ago IST
According to the stock market filing with the National Stock Exchange, the U.S. FDA carried out the inspection between June 10 to June 13, 2024, and concluded with zero 483 observations. The pharma major said in its filing, "The United States Food and Drug Administration (U.S. FDA) has compl
Read More
Cipla secures USFDA approval for pancreatic disease injection, shares surg
Updated : 1 year, 10 months ago IST
Mumbai-headquartered pharma major, Cipla's US arm has secured final approval from the United States Food and Drug Administration (USFDA) for its Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, and 60 mg/0.2 mL.
Read More
"A reiteration of India's progress": Bharat Biotech co-founder on VP Dhank
Updated : 1 year, 11 months ago IST
Speakig to ANI on Friday, Ella said, "It has been a very special day at Bharat Biotech because the tradition of having dignitaries such as the Vice President, the second lady and also the Telangana governor is the reiteration of the work and journey that we have taken forward over the las
Read More
Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg,
Updated : 2 years, 4 months ago IST
Ahmedabad (Gujarat) [India], November 3: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") a discovery-driven, global lifesciences company and Lupin Limited (Lupin), a global pharma major, today announced that they have entered into a licensi
Read More
Indian API Pharma Major Flawless Pharma Signs API Deal with European and A
Updated : 2 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 12: Flawless Pharma Pvt. Ltd. has engaged with a major European contract development and manufacturing organization (CDMO) & a leading African firm in Africa for the export & supply of the active ingredient of the Anti-cancer and Anti-viral drugs
Read More
Lupin gets US regulator's nod for Prasugrel tablets used in heart ailments
Updated : 3 years, 2 months ago IST
The product will be manufactured at Lupin's facility in Goa, according to a statement from the pharma firm.
Read More
T'gana Cong leader Jagga Reddy slams TRS for nominating Parthasaradhi Redd
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], May 24 (ANI): Telangana Congress working president Aredla Jagadeeshwar Reddy (Jagga Reddy) slammed the state government for nominating prominent industrialist Bandi Parthasaradhi Reddy to the Rajya Sabha.
Read More